Sonnet BioTherapeutics Holdings, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (11)

Latest Posts

About This Stock More About This Stock
64 Biggest Movers From Yesterday
Article By: Benzinga
Thursday, August 27, 2020 5:04 AM EST
Here are the best gainers and losers moving in pre-market.
In this article: DKS, EXPR, LRN, RIG, AMTX, FARM, CRM, DY, JWN, NIO, VHI, CHCI, GEVO, KIRK, BKYI, FLDM, INOD, CYRX, IMBI, VNET, BGFV, PEIX, ADBE, HIBB, KELYB, URBN, PPSI, NFLX, CAAS, CNSP, GOGO, WORX, WDAY, VJET, HPE, NAKD, ALT, PLAN, XSPA, TRUP, PSTG, OCUL, ANY, LPCN, CWBR, BIGC, EVSI, FLNT, MICT, GTX, IMUX, SWBI, SONN, BRQS, ORTX, UONE, BLI, RUHN, AYRO, EDNT, KROS, LI, OCGN, DNK
Read
Sonnet Biotherapeutics Plummets By Nearly 20% After Medical Community Rebukes FDA
Article By: FXStreet
Wednesday, August 26, 2020 2:13 PM EST
The announcement by the FDA over the weekend about a shift in focus towards convalescent plasma therapies as a viable coronavirus treatment sent shockwaves through the biotech industry.
In this article: SONN
Read
38 Stocks Moving In Wednesday's Pre-Market Session
Article By: Benzinga
Wednesday, August 26, 2020 7:00 AM EST
Here are the best gainers and losers moving in pre-market.
In this article: CRM, JWN, RIG, IGC, BKYI, SRNE, FLDM, GERN, GEVO, ICON, INTU, URBN, CAAS, KNDI, PPSI, WORX, PSTG, HPE, NAKD, ZSAN, OPGN, VIVE, LPCN, BPTH, IMUX, CWBR, BIGC, SONN, MYT, EVSI, IMVT, SOLO, BLCT, BRQS, OCGN, DFFN, EXPR, XSPA
Read
Sonnet BioTherapeutics Receives $10.5 Million From Exercise Of Series A Warrants
Article By: TalkMarkets Newswire
Tuesday, August 25, 2020 9:00 AM EST
Sonnet Bio announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.
In this article: SONN
Read
Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod
Article By: Smarter Analyst
Monday, August 24, 2020 7:37 AM EST
SONN is spiking 70% in Monday’s pre-market trading on news that the U.S. Food & Drug Administration (FDA) has granted an emergency authorization to use blood plasma from recovered Covid-19 patients as a treatment for the disease.
In this article: SONN
Read

Latest Tweets for $SONN

No tweets yet!